Diagnosis and management of prosthetic vascular graft infections

Medecine et Maladies Infectieuses

Volumn 42, Issue 3, 2012, Pages 102-109

  Legout, L ^a   D'Elia, P V ^a,b   Sarraz Bournet, B ^a   Haulon, S ^b   Meybeck, A ^a   Senneville, E ^a   Leroy, O ^a  

^a CENTRE HOSPITALIER DE TOURCOING   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Allograft; Biofilm; Vascular graft infection

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PROCALCITONIN;

ANTIBIOTIC THERAPY; BLOOD CULTURE; BLOOD VESSEL GRAFT; BLOOD VESSEL PROSTHESIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEVICE REMOVAL; DIAGNOSTIC IMAGING; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; NEUTROPHIL COUNT; POSITRON EMISSION TOMOGRAPHY; PROSTHESIS INFECTION; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TREATMENT DURATION;

AFTERCARE; ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BACTERIAL INFECTIONS; BLOOD VESSEL PROSTHESIS; COMBINED MODALITY THERAPY; CONTRAST MEDIA; DEVICE REMOVAL; DIAGNOSTIC IMAGING; DISEASE MANAGEMENT; DRUG RESISTANCE, MICROBIAL; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSTHESIS-RELATED INFECTIONS; REOPERATION; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER;

EID: 84858745748     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2012.01.003     Document Type: Review

References (75)

1. Seeger J.M. Management of patients with prosthetic vascular graft infection. Am Surg 2000, 66(2):166-177.
2. FitzGerald S.F., Kelly C., Humphreys H. Diagnosis and treatment of prosthetic aortic graft infections: confusion and inconsistency in the absence of evidence or consensus. J Antimicrob Chemother 2005, 56(6):996-999.
3. Antonios V.S., Noel A.A., Steckelberg J.M., et al. Prosthetic vascular graft infection: a risk factor analysis using a case-control study. J Infect 2006, 53(1):49-55.
4. Legout L, Sarraz-Bournet B, D'Elia PV, et al. Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study. Clin Microbiol Infect 2011.
5. Kieffer E., Sabatier J., Plissonnier D., Knosalla C. Prosthetic graft infection after descending thoracic/thoracoabdominal aortic aneurysmectomy: management with in situ arterial allografts. J Vasc Surg 2001, 33(4):671-678.
6. O'Connor S., Andrew P., Batt M., Becquemin J.P. A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg 2006, 44(1):38-45.
7. O'Hara P.J., Hertzer N.R., Beven E.G., Krajewski L.P. Surgical management of infected abdominal aortic grafts: review of a 25-year experience. J Vasc Surg 1986, 3(5):725-731.
8. Szczot M., Meybeck A., Legout L., et al. Vascular graft infections in the intensive care unit: clinical spectrum and prognostic factors. J Infect 2011, 62(3):204-211.
9. Javerliat I., Goeau-Brissonniere O., Sivadon-Tardy V., Coggia M., Gaillard J.L. Prevention of Staphylococcus aureus graft infection by a new gelatin-sealed vascular graft prebonded with antibiotics. J Vasc Surg 2007, 46(5):1026-1031.
10. Stephen M., Sheil A.G., Wong J. Allograft vein arterial bypass. Arch Surg 1978, 113(5):591-593.
11. Castier Y., Paraskevas N., Maury J.M., et al. Cryopreserved arterial allograft reconstruction for infected peripheral bypass. Ann Vasc Surg 2010, 24(8):994-999.
12. Vardanian A.J., Chau A., Quinones-Baldrich W., Lawrence P.E. Arterial allograft allows in-line reconstruction of prosthetic graft infection with low recurrence rate and mortality. Am Surg 2009, 75(10):1000-1003.
13. Zetrenne E., McIntosh B.C., McRae M.H., Gusberg R., Evans G.R., Narayan D. Prosthetic vascular graft infection: a multi-center review of surgical management. Yale J Biol Med 2007, 80(3):113-121.
14. Chiesa R., Astore D., Frigerio S., et al. Vascular prosthetic graft infection: epidemiology, bacteriology, pathogenesis and treatment. Acta Chir Belg 2002, 102(4):238-247.
15. Goeau-Brissonniere O., Mercier F., Nicolas M.H., et al. Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft. J Vasc Surg 1994, 19(4):739-741.
16. Leseche G., Castier Y., Petit M.D., et al. Long-term results of cryopreserved arterial allograft reconstruction in infected prosthetic grafts and mycotic aneurysms of the abdominal aorta. J Vasc Surg 2001, 34(4):616-622.
17. Hernandez-Richter T., Wittmann F., Mayr S., et al. Experimental examination concerning the efficacy of silver-coated Dacron prostheses in vascular graft infections following subcutaneous implantation in a standardized infection model. Zentralbl Chir 2003, 128(3):244-249.
18. Saleem B.R., Meerwaldt R., Tielliu I.F., Verhoeven E.L., van den Dungen J.J., Zeebregts C.J. Conservative treatment of vascular prosthetic graft infection is associated with high mortality. Am J Surg 2010, 200(1):47-52.
19. Martinez-Vazquez C., Sopena B., Oliveira I., et al. Vascular graft-associated infection: successful management without graft removal. Rev Clin Esp 2007, 207(7):317-321.
20. Heath D.I. Is a conservative approach to vascular graft infection feasible?. J R Coll Surg Edinb 1987, 32(1):65.
21. Bandyk D.F., Esses G.E. Prosthetic graft infection. Surg Clin North Am 1994, 74(3):571-590.
22. Calligaro K.D., Veith F.J., Schwartz M.L., Dougherty M.J., DeLaurentis D.A. Differences in early versus late extracavitary arterial graft infections. J Vasc Surg 1995, 22(6):680-685. [discussion 5-8].
23. Lorenz U., Schafer T., Ohlsen K., et al. In vivo detection of Staphylococcus aureus in biofilm on vascular prostheses using non-invasive biophotonic imaging. Eur J Vasc Endovasc Surg 2011, 41(1):68-75.
24. Bergamini T.M., Bandyk D.F., Govostis D., Kaebnick H.W., Towne J.B. Infection of vascular prostheses caused by bacterial biofilms. J Vasc Surg 1988, 7(1):21-30.
25. Tollefson D.F., Bandyk D.F., Kaebnick H.W., Seabrook G.R., Towne J.B. Surface biofilm disruption. Enhanced recovery of microorganisms from vascular prostheses. Arch Surg 1987, 122(1):38-43.
26. Petrelli D., Repetto A., Di Luca M.C., et al. Characterization of a Staphylococcus aureus strain showing high levels of biofilm formation isolated from a vascular graft: case report. Int J Immunopathol Pharmacol 2008, 21(3):745-750.
27. Hicks R.C., Greenhalgh R.M. The pathogenesis of vascular graft infection. Eur J Vasc Endovasc Surg 1997, 14(Suppl. A):5-9.
28. Herscu G., Wilson S.E. Prosthetic infection: lessons from treatment of the infected vascular graft. Surg Clin North Am 2009, 89(2):391-401. [viii].
29. Bergamini T.M., Bandyk D.F., Govostis D., Vetsch R., Towne J.B. Identification of Staphylococcus epidermidis vascular graft infections: a comparison of culture techniques. J Vasc Surg 1989, 9(5):665-670.
30. Bandyk D.F., Novotney M.L., Back M.R., Johnson B.L., Schmacht D.C. Expanded application of in situ replacement for prosthetic graft infection. J Vasc Surg 2001, 34(3):411-419. [discussion 9-20].
31. Recommendations for bone and joint prosthetic device infections in clinical practice (prosthesis, implants, osteosynthesis). Société de pathologie infectieuse de langue française. Med Mal Infect 2010, 40(4):185-211.
32. Calabrese F., Carturan E., Thiene G. Cardiac infections: focus on molecular diagnosis. Cardiovasc Pathol 2010, 19(3):171-182.
33. Fournier P.E., Thuny F., Richet H., et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis 2010, 51(2):131-140.
34. Moter A., Musci M., Schmiedel D. Molecular methods for diagnosis of infective endocarditis. Curr Infect Dis Rep 2010, 12(4):244-252.
35. Vondracek M., Sartipy U., Aufwerber E., Julander I., Lindblom D., Westling K. 16S rDNA sequencing of valve tissue improves microbiological diagnosis in surgically treated patients with infective endocarditis. J Infect 2011, 62(6):472-478.
36. Senn L., Franciolli M., Raoult D., et al. Coxiella burnetii vascular graft infection. BMC Infect Dis 2005, 5:109.
37. Le Page L., Podglajen I., Chemla E., Mainardi J.L. Molecular diagnosis of a vascular prosthesis infection, due to Propionibacterium acnes, by amplification and sequencing of 16S rDNA. Clin Microbiol Infect 2003, 9(11):1125-1127.
38. Marques da Silva R., Caugant D.A., Eribe E.R., et al. Bacterial diversity in aortic aneurysms determined by 16S ribosomal RNA gene analysis. J Vasc Surg 2006, 44(5):1055-1060.
39. Low R.N., Wall S.D., Jeffrey R.B., Sollitto R.A., Reilly L.M., Tierney L.M. Aortoenteric fistula and perigraft infection: evaluation with CT. Radiology 1990, 175(1):157-162.
40. Haaga J.R., Baldwin G.N., Reich N.E., et al. CT detection of infected synthetic grafts: preliminary report of a new sign. AJR Am J Roentgenol 1978, 131(2):317-320.
41. O'Hara P.J., Borkowski G.P., Hertzer N.R., O'Donovan P.B., Brigham S.L., Beven E.G. Natural history of periprosthetic air on computerized axial tomographic examination of the abdomen following abdominal aortic aneurysm repair. J Vasc Surg 1984, 1(3):429-433.
42. Qvarfordt P.G., Reilly L.M., Mark A.S., et al. Computerized tomographic assessment of graft incorporation after aortic reconstruction. Am J Surg 1985, 150(2):227-231.
43. Bruggink J.L., Glaudemans A.W., Saleem B.R., et al. Accuracy of FDG-PET-CT in the diagnostic work-up of vascular prosthetic graft infection. Eur J Vasc Endovasc Surg 2010, 40(3):348-354.
44. Fukuchi K., Ishida Y., Higashi M., et al. Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: comparison with computed tomographic findings. J Vasc Surg 2005, 42(5):919-925.
45. Fiorani P., Speziale F., Rizzo L., et al. Detection of aortic graft infection with leukocytes labeled with technetium 99m-hexametazime. J Vasc Surg 1993, 17(1):87-95. [discussion -6].
46. Orton D.F., LeVeen R.F., Saigh J.A., et al. Aortic prosthetic graft infections: radiologic manifestations and implications for management. Radiographics 2000, 20(4):977-993.
47. Katz B.H., Black R.A., Colley D.P. CT-guided fine needle aspiration of a periaortic collection. J Vasc Surg 1987, 5(5):762-764.
48. Siegel C.L., Cohan R.H., Korobkin M., Alpern M.B., Courneya D.L., Leder R.A. Abdominal aortic aneurysm morphology: CT features in patients with ruptured and nonruptured aneurysms. AJR Am J Roentgenol 1994, 163(5):1123-1129.
49. Spartera C., Morettini G., Petrassi C., Di Cesare E., La Barbera G., Ventura M. Healing of aortic prosthetic grafts: a study by magnetic resonance imaging. Ann Vasc Surg 1994, 8(6):536-542.
50. Olofsson P.A., Auffermann W., Higgins C.B., Rabahie G.N., Tavares N., Stoney R.J. Diagnosis of prosthetic aortic graft infection by magnetic resonance imaging. J Vasc Surg 1988, 8(2):99-105.
51. Spartera C., Morettini G., Petrassi C., et al. Role of magnetic resonance imaging in the evaluation of aortic graft healing, perigraft fluid collection, and graft infection. Eur J Vasc Surg 1990, 4(1):69-73.
52. Spartera C., Morettini G., Bafile C., Di Cesare E., Alagia G., Ventura M. Diagnostic imaging techniques in vascular graft infection. Eur J Vasc Surg 1997, 14(Suppl. A):24-26.
53. Bar-Shalom R., Yefremov N., Guralnik L., et al. SPECT/CT using 67Ga and 111In-labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med 2006, 47(4):587-594.
54. Mark A.S., McCarthy S.M., Moss A.A., Price D. Detection of abdominal aortic graft infection: comparison of CT and in-labeled white blood cell scans. AJR Am J Roentgenol 1985, 144(2):315-318.
55. Johnson K.K., Russ P.D., Bair J.H., Friefeld G.D. Diagnosis of synthetic vascular graft infection: comparison of CT and gallium scans. AJR Am J Roentgenol 1990, 154(2):405-409.
56. Spacek M., Belohlavek O., Votrubova J., Sebesta P., Stadler P. Diagnostics of " non-acute" vascular prosthesis infection using 18F-FDG PET/CT: our experience with 96 prostheses. Eur J Nucl Med Mol Imaging 2009, 36(5):850-858.
57. Stadler P., Bilohlavek O., Spacek M., Michalek P. Diagnosis of vascular prosthesis infection with FDG-PET/CT. J Vasc Surg 2004, 40(6):1246-1247.
58. Keidar Z., Engel A., Nitecki S., Bar-Shalom R., Hoffman A., Israel O. PET/CT using 2-deoxy-2-[18F]fluoro-D-glucose for the evaluation of suspected infected vascular graft. Mol Imaging Biol 2003, 5(1):23-25.
59. Zimmerman P.M., Cherr G.S., Angelo G.C., Gona J., Dosluoglu H.H. Is F 18 fluorodeoxyglucose positron emission tomography too sensitive for the diagnosis of vascular endograft infection?. Vascular 2008, 16(6):346-349.
60. Keidar Z., Engel A., Hoffman A., Israel O., Nitecki S. Prosthetic vascular graft infection: the role of 18F-FDG PET/CT. J Nucl Med 2007, 48(8):1230-1236.
61. Zimmerli W., Trampuz A., Ochsner P.E. Prosthetic-joint infections. N Engl J Med 2004, 351(16):1645-1654.
62. Taylor J. The 2009 ESC Guidelines for management of infective endocarditis reviewed. Eur Heart J 2009, 30(19):2185-2186.
63. Szilagyi D.E., Smith R.F., Elliott J.P., Vrandecic M.P. Infection in arterial reconstruction with synthetic grafts. Ann Surg 1972, 176(3):321-333.
64. Samson R.H., Veith F.J., Janko G.S., Gupta S.K., Scher L.A. A modified classification and approach to the management of infections involving peripheral arterial prosthetic grafts. J Vasc Surg 1988, 8(2):147-153.
65. Cirioni O., Mocchegiani F., Ghiselli R., et al. Daptomycin and rifampin alone and in combination prevent vascular graft biofilm formation and emergence of antibiotic resistance in a subcutaneous rat pouch model of staphylococcal infection. Eur J Vasc Endovasc Surg 2010, 40(6):817-822.
66. Edmiston C.E., Goheen M.P., Seabrook G.R., et al. Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices. Am J Surg 2006, 192(3):344-354.
67. LaPlante K.L., Rybak M.J. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 2004, 48(12):4665-4672.
68. Smith K., Perez A., Ramage G., Gemmell C.G., Lang S. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin. Int J Antimicrob Agents 2009, 33(4):374-378.
69. Tsuji B.T., Rybak M.J. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother 2005, 49(7):2735-2745.
70. Meddahi-Pelle A., Bataille I., Subra P., Letourneur D. Vascular biomaterials: from biomedical engineering to tissue engineering. Med Sci (Paris) 2004, 20(6-7):679-684.
71. Chan F.Y., Crawford E.S., Coselli J.S., Safi H.J., Williams T.W. In situ prosthetic graft replacement for mycotic aneurysm of the aorta. Ann Thorac Surg 1989, 47(2):193-203.
72. Calligaro K.D., Veith F.J., Yuan J.G., Gargiulo N.J., Dougherty M.J. Intra-abdominal aortic graft infection: complete or partial graft preservation in patients at very high risk. J Vasc Surg 2003, 38(6):1199-1205.
73. Calligaro K.D., Veith F.J. Graft preserving methods for managing aortofemoral prosthetic graft infection. Eur J Vasc Endovasc Surg 1997, 14(Suppl. A):38-42.
74. Habib G., Hoen B., Tornos P., et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for infection and cancer. Eur Heart J 2009, 30(19):2369-2413.
75. Liu C., Bayer A., Cosgrove S.E., et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011, 52(3):e18-e55.